Kang; Xinshan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kang; Xinshan.The latest application filed is for "compound and use thereof in synthesis of brivaracetam intermediate and crude drug".

Company Profile

0.19.14

Kang; Xinshan - Beijing CN
Kang; Xinshan - Pine Brook NJ
Kang; Xinshan - Fujian N/A CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compound and use thereof in synthesis of brivaracetam intermediate and crude drug Grant 11,247,977 - Feng , et al. February 15, 2	2022-02-15
Compound And Use Thereof In Synthesis Of Brivaracetam Intermediate And Crude Drug App 20210261515 - FENG; Yan ; et al.	2021-08-26
Modulation of chemosensory receptors and ligands associated therewith Grant 9,603,848 - Servant , et al. March 28, 2	2017-03-28
Compound for increasing kinase active and application thereof Grant 9,409,900 - Kang , et al. August 9, 2	2016-08-09
Carboxylic Acid Compounds In Treatment Of Diabetes Mellitus App 20160200734 - KANG; Xinshan ; et al.	2016-07-14
Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof Grant 9,238,637 - Kang , et al. January 19, 2	2016-01-19
Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof Grant 9,206,134 - Kang , et al. December 8, 2	2015-12-08
Modulation of chemosensory receptors and ligands associated therewith Grant 9,181,276 - Tachdjian , et al. November 10, 2	2015-11-10
Polymorphic Forms Of Compounds As Prolyl Hydroxylase Inhibitor, And Uses Thereof App 20150031721 - Kang; Xinshan ; et al.	2015-01-29
Stable Polymorphic Forms of Compound as Hypoxia Mimetics, and Uses Thereof App 20140343137 - Kang; Xinshan ; et al.	2014-11-20
Compounds as hypoxia mimetics, and compositions and uses thereof Grant 8,742,138 - Kang , et al. June 3, 2	2014-06-03
Modulation of chemosensory receptors and ligands associated therewith Grant 8,633,186 - Tachdjian , et al. January 21, 2	2014-01-21
Methods of enhancing sweet taste of compositions using substituted thieno{2,3-D}pyrimidines Grant 8,541,421 - Tachdjian , et al. September 24, 2	2013-09-24
Compound For Increasing Kinase Active And Application Thereof App 20130225587 - Kang; Xinshan ; et al.	2013-08-29
Compounds As Hypoxia Mimetics, And Composiitons And Uses Thereof App 20120172399 - Kang; Xinshan ; et al.	2012-07-05
Modulation Of Chemosensory Receptors And Ligands Associated Therewith App 20110230502 - TACHDJIAN; Catherine ; et al.	2011-09-22
Modulation Of Chemosensory Receptors And Ligands Associated Therewith App 20110224155 - Tachdjian; Catherine ; et al.	2011-09-15
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors Grant 7,928,111 - Tachdjian , et al. April 19, 2	2011-04-19
Modulation Of Chemosensory Receptors And Ligands Associated Therewith App 20080306053 - Tachdjian; Catherine ; et al.	2008-12-11
Modulation Of Chemosensory Receptors And Ligands Associated Therewith App 20080306093 - Servant; Guy ; et al.	2008-12-11
Modulation Of Chemosensory Receptors And Ligands Associated Therewith App 20080306076 - Li; Xiaodong ; et al.	2008-12-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.